HR4392Referred to Committee

Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-07-15
Introduced
54
Cosponsors
HR
ⓘ
Type

Sponsor

Shontel M. Brown
Shontel M. Brown
Democrat · OH · Representative
Votes with party: 98.5% (607 recorded votes)

Full profile: /officials/B001313

Source: Congress.gov · FEC

Cosponsors (54)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2025-07-15

Source: Congress.gov

Committee Activity

Currently in

Previously

Plain-English Summary

This bill would increase federal funding and research efforts focused on uterine fibroids—noncancerous tumors that grow in the uterus and affect many women—and improve treatment options and patient care for this condition. The legislation aims to support medical research, education for healthcare providers, and better access to gynecological treatments for women dealing with fibroids. It would primarily benefit women's health by expanding knowledge about the condition and making care more available and effective.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.